Caxton Associates LP Petmed Express Inc Transaction History

Caxton Associates LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$25.26 - $32.0 $499,415 - $632,672	-19,771 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$26.5 - $34.0 $161,358 - $207,026	6,089 Added 44.5%	19,771 $531,000
Q2 2021 Aug 16, 2021	BUY	$27.73 - $46.06 $79,640 - $132,284	2,872 Added 26.57%	13,682 $436,000
Q1 2021 May 17, 2021	BUY	$29.77 - $51.8 $321,813 - $559,958	10,810 New	10,810 $380,000
Q3 2020 Nov 16, 2020	SELL	$29.0 - $41.83 $515,127 - $743,026	-17,763 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$27.94 - $40.96 $496,298 - $727,572	17,763 New	17,763 $633,000
Q2 2018 Aug 14, 2018	SELL	$33.46 - $46.17 $169,508 - $233,897	-5,066 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$34.19 - $48.11 $173,206 - $243,725	5,066	5,066 $231,000

102

9.52M

39.6K

137K

Ticker PETS
Exchange NASDAQ
Sector Healthcare
Industry Pharmaceutical Retailers
Shares Outstandng 21,013,800
Market Cap $102M
Description
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint c...

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

Stay updated on Caxton Associates LP with notifications on news.